F&S Pharmatech

Fineline Info & Tech (Flcube.com) provides you with comprehensive information about F&S Pharmatech, including details on the company, its pharmaceuticals, policies, deals, healthcare enterprises, research and development, hospitals, legal patents, and internet healthcare. More information about F&S Pharmatech please access flcube.comFineline Info & Tech (Flcube.com) provides you with comprehensive information about F&S Pharmatech, including details on the company, its pharmaceuticals, policies, deals, healthcare enterprises, research and development, hospitals, legal patents, and internet healthcare. More information about F&S Pharmatech please access flcube.com

NMPA Approves New Indication for J&J's Tecvayli in Relapsed or Refractory Multiple Myeloma – Bispecific BCMA/CD3 Antibody Moves to First Relapse After ≥1 Prior Line
CompanyDrug

NMPA Approves New Indication for J&J’s Tecvayli in Relapsed or Refractory Multiple Myeloma – Bispecific BCMA/CD3 Antibody Moves to First Relapse After ≥1 Prior Line

Johnson & Johnson (J&J) (NYSE: JNJ) announced that China's National Medical Products Administration (NMPA) has approved a new indication for Tecvayli (teclistamab injection) for adult patients with relapsed or refractory…

Enhertu Approved in China as First Tumor-Agnostic HER2-Targeted Therapy – Daiichi Sankyo's ADC Wins Conditional Approval for HER2-Expressing Solid Tumors

Enhertu Approved in China as First Tumor-Agnostic HER2-Targeted Therapy – Daiichi Sankyo’s ADC Wins Conditional Approval for HER2-Expressing Solid Tumors

Yifan Pharmaceutical Signs Exclusive Commercialization Agreement With Eisai for Halaven in Mainland China – Originator Anti-Tumor Drug Strengthens Oncology Portfolio

Yifan Pharmaceutical Signs Exclusive Commercialization Agreement With Eisai for Halaven in Mainland China – Originator Anti-Tumor Drug Strengthens Oncology Portfolio

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Chinese Firms Nanjing F&S and Hunan Huize Form Alliance for Full-Process Pharma Services
CompanyDeals

Chinese Firms Nanjing F&S and Hunan Huize Form Alliance for Full-Process Pharma Services

CompanyDrug

ClouDr Launches Dapagliflozin, Generic Version of AstraZeneca’s Forxiga, After NMPA Approval

CompanyDrug

Shanghai Fosun to Exclusively Commercialize Generic Entresto in China

CompanyDrug

CSPC Pharmaceutical’s Generic Entresto Approved in China for Heart Failure Treatment

CompanyDrug

Nanjing F&S Pharmatech Secures First Generic Approval for Novartis’s Entresto in China